These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10348579)

  • 1. Adjunctive abciximab improves outcomes during recanalization of totally occluded saphenous vein grafts using transluminal extraction atherectomy.
    Sullebarger JT; Dalton RD; Nasser A; Matar FA
    Catheter Cardiovasc Interv; 1999 Jan; 46(1):107-10. PubMed ID: 10348579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and angiographic results of transluminal extraction coronary atherectomy in saphenous vein bypass grafts.
    Safian RD; Grines CL; May MA; Lichtenberg A; Juran N; Schreiber TL; Pavlides G; Meany TB; Savas V; O'Neill WW
    Circulation; 1994 Jan; 89(1):302-12. PubMed ID: 8281662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of abciximab on cardiac enzyme elevation after transluminal extraction atherectomy (TEC) in high-risk saphenous vein graft lesions: comparison with a historical control group.
    Khan MA; Liu MW; Chio FL; Yates VB; Chapman GD; Misra VK; Sweeney A; Dean LS
    Catheter Cardiovasc Interv; 2001 Jan; 52(1):40-4. PubMed ID: 11146520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recanalization of Chronically Occluded Aortocoronary Saphenous Vein Bypass Grafts With Long-Term, Low Dose Direct Infusion of Urokinase (ROBUST): a serial trial.
    Hartmann JR; McKeever LS; O'Neill WW; White CJ; Whitlow PL; Gilmore PS; Doorey AJ; Galichia JP; Enger EL
    J Am Coll Cardiol; 1996 Jan; 27(1):60-6. PubMed ID: 8522711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein grafts. EPIC Investigators. Evaluation of IIb/IIIa platelet receptor antagonist 7E3 in Preventing Ischemic Complications.
    Mak KH; Challapalli R; Eisenberg MJ; Anderson KM; Califf RM; Topol EJ
    Am J Cardiol; 1997 Oct; 80(8):985-8. PubMed ID: 9352964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTCA, thrombolysis or atherectomy: rational treatment of recently occluded saphenous vein grafts.
    Mehta S; Margolis JR; Moore L; Pena R
    Indian Heart J; 1995; 47(5):481-4. PubMed ID: 8714502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced distal embolization with transluminal extraction atherectomy compared to balloon angioplasty for saphenous vein graft disease.
    Misumi K; Matthews RV; Sun GW; Mayeda G; Burstein S; Shook TL
    Cathet Cardiovasc Diagn; 1996 Nov; 39(3):246-51. PubMed ID: 8933966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of distal embolization and infarction with transluminal extraction atherectomy in saphenous vein grafts and native coronary arteries. NACI Investigators. New Approaches to Coronary Interventions.
    Moses JW; Moussa I; Popma JJ; Sketch MH; Yeh W
    Catheter Cardiovasc Interv; 1999 Jun; 47(2):149-54. PubMed ID: 10376493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transluminal extraction catheter atherectomy followed by immediate stenting in treatment of saphenous vein grafts.
    Braden GA; Xenopoulos NP; Young T; Utley L; Kutcher MA; Applegate RJ
    J Am Coll Cardiol; 1997 Sep; 30(3):657-63. PubMed ID: 9283522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extraction atherectomy for the recanalization of totally occluded aortocoronary saphenous vein grafts.
    Sullebarger JT; Puleo J
    Cathet Cardiovasc Diagn; 1995 Dec; 36(4):339-43. PubMed ID: 8719387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recanalization of chronically occluded aortocoronary saphenous vein bypass grafts by extended infusion of urokinase: initial results and short-term clinical follow-up.
    Hartmann JR; McKeever LS; Stamato NJ; Bufalino VJ; Marek JC; Brown AS; Goodwin MJ; Cahill JM; Enger EL
    J Am Coll Cardiol; 1991 Nov; 18(6):1517-23. PubMed ID: 1939955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-year follow-up of recanalization of totally occluded aortocoronary saphenous vein grafts using transluminal extraction atherectomy.
    Sullebarger JT; Dalton RD; Tauth JG; Matar FA
    Am J Cardiol; 1998 Mar; 81(5):636-8. PubMed ID: 9514464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of saphenous vein bypass grafts with ultrasound thrombolysis: a randomized study (ATLAS).
    Singh M; Rosenschein U; Ho KK; Berger PB; Kuntz R; Holmes DR
    Circulation; 2003 May; 107(18):2331-6. PubMed ID: 12732601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of glycoprotein IIb/IIIa inhibitors in the treatment of degenerated aortocoronary saphenous vein grafts].
    Brück M; Ludwig J; Flachskampf FA; Daniel WG
    Z Kardiol; 2002 Jan; 91(1):16-23. PubMed ID: 11963202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late outcomes after intervention of vein grafts in diabetics with abciximab use.
    Applegate RJ; Upadhya B; Little WC; Xenakis M; Gandhi SK; Baki TT; Kahl FR; Kutcher MA
    Int J Cardiol; 2006 Jul; 111(1):136-41. PubMed ID: 16226815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-graft abciximab and verapamil combined with direct stenting is a safe and effective strategy to prevent slow-flow and no-reflow phenomenon in saphenous vein graft lesions not associated with thrombus.
    Sharma S; Lardizabal JA; Singh S; Sandhu R; Bhambi BK
    Recent Pat Cardiovasc Drug Discov; 2012 Aug; 7(2):152-9. PubMed ID: 22559269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous revascularization of ostial saphenous vein graft stenoses.
    Abdel-Meguid AE; Whitlow PL; Simpfendorfer C; Sapp SK; Franco I; Ellis SG; Topol EJ
    J Am Coll Cardiol; 1995 Oct; 26(4):955-60. PubMed ID: 7560623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative results of transluminal extraction coronary atherectomy in saphenous vein graft lesions with and without thrombus.
    Dooris M; Hoffmann M; Glazier S; Juran N; Reddy V; Grines CL; Pavlides GS; Schreiber T; O'Neill WW; Safian RD
    J Am Coll Cardiol; 1995 Jun; 25(7):1700-5. PubMed ID: 7759726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-molecular-weight heparin and abciximab for thrombo-occlusive saphenous vein graft disease. Report of 2 cases.
    Yaryura R; Doucet J; Mathur VS
    Tex Heart Inst J; 1997; 24(4):379-83. PubMed ID: 9456497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute results and long-term outcome of transluminal extraction catheter atherectomy for saphenous vein graft stenoses.
    Twidale N; Barth CW; Kipperman RM; Bowles MH; Galichia JP
    Cathet Cardiovasc Diagn; 1994 Mar; 31(3):187-91. PubMed ID: 8025934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.